Skip to main content
Home

Breadcrumb

  1. Home
  2. Consultancy

Consultancy

19 January 2023

Hat trick for cofinitive in New Year Honours listing

With such a flourishing tech cluster in Cambridge, it is with huge delight that cofinitive is listed as #1 for the third year running for leading the area as Image Maker for many of our entrepreneurial tech companies. ...

18 January 2023

Measuring the dew point for nitrogen and oxygen in gas generators

For many companies, there are considerable advantages to using industrial gas generators, rather than traditional bottled or tanker supply to on-site silos. However, the benefits only accrue if the gas generator is operating at optimum levels of efficiency and reliability. This is where...

2 July 2026

Cambridge Startup to DeepTech Unicorn w/ Poppy Gustafsson, CEO of Darktrace

Our featured guest to launch the Cambridge Chapter of Founder Institute is Poppy Gustafsson, CEO of Darktrace. She's the recipient of an Order of the British Empire (OBE) for services to cybersecurity. ...

18 January 2023

How much do you know about cloud security?

The growth of cloud computing has completely changed the way many of us work. It’s also changed the way we need to think about security. ...

3 January 2023

cofinitive Communications Clinic

cofinitive first began holding its monthly Communications Clinic at The Bradfield Centre in 2018 and it remains as popular as ever. ...

17 January 2023

Carbon Orange - Now we are six

Carbon Orange writes: It's been a while since our last update, but now seems like a good time to pop back so you can celebrate our 6th birthday with us! ...

12 January 2023

The year in review: Updates and trends

In 2022, everyone witnessed intense activity in matters related to supply chain issues, the energy transition, oil & gas, post-M&A disputes, licensing issues, breaches of distribution contracts and increasingly arbitrations deriving from geopolitical issues in Europe and Asia an...

14 December 2022

Assessing the impact of rarity on French HTA and pricing decisions

With changes to the pricing and access processes such as the new Accord Cadre and the soon-to-be implemented ATU reform likely to impact pricing and access of orphan products in France, Cécile Matthews, Bhavesh Patel, and Owen Male look at how French payers have valu...

9 December 2022

How eligible patient numbers affect price of rare disease drugs in France

Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Cécile Matthews, Bhavesh Patel, and Owen Male explore in greater depth the situation for these orphan drugs in France in this final article of a three-part series publis...

9 December 2022

France’s ATU reform: Early access remains possible, but not all diseases are equal

When France’s ATU reform was implemented, some viewed it as restrictive. In this article published in European Pharmaceutical Review (EPR), Cécile Matthews and Charlotte Capdevila explore the reform’s impact on early access to oncology drugs and products for rare diseases. ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 95
  • Page 96
  • Current page 97
  • Page 98
  • Page 99
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS